EarningsSQURPHARMA
SQURPHARMA Earnings Update
Announcement summary
- What happened
- SQURPHARMA published a corporate disclosure on 30 April 2018. Read the full announcement for details.
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
(Q3 Un-audited): Consolidated EPS was Tk. 4.04 for January-March 2018 as against Tk. 3.98 for January-March 2017; Consolidated EPS was Tk. 11.99 for July 2017-March 2018 as against Tk. 10.59 for July 2016-March 2017. Consolidated NOCFPS was Tk. 11.26 for July 2017-March 2018 as against Tk. 11.49 for July 2016-March 2017. Consolidated NAV per share was Tk. 74.75 as on March 31, 2018 and Tk. 66.49 as on June 30, 2017.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616acef05a6b00004005cd50
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.